A recent study has demonstrated a significant decrease in cases of HPV infections in England since the introduction of a bivalent vaccine in 2008.
Browsing: cervical cancer
Discover the case of a heavily pretreated patient with recurrent advanced squamous cell carcinoma of the cervix who had exhausted all available treatments and demonstrated a striking response to pembrolizumab.
To mark Cervical Cancer Awareness Week we have collated our most-popular cervical cancer content.
Blueberry extract has been shown to improve success rate of radiation therapy in patients with cervical cancer.
A new study has demonstrated that women may only need three cervical screens in their lifetime if they have received the HPV vaccine.
In 2017, every woman in Australia aged 37 years and younger is already better protected against HPV than ever before – this is a huge milestone and a truly remarkable feat. How was this achieved and what hurdles still exist? Find out in this exclusive opinion piece.
New findings suggest that women who receive human papillomavirus (HPV) testing as well as a Pap smear obtain a faster and more complete diagnosis of cervical disease.
Expression of Sialyl Lewis a, Sialyl Lewis x, Lewis y, Gal-3, Gal-7, STMN1 and p16 in cervical dysplasia
In this review article from Future Oncology the authors highlight why we may need to reconsider the grading of cervical intraepithelial neoplasia.
ASCO release guidance for HPV vaccination for cervical cancer prevention adapted for multiple regions of the world with differing socio-economic statuses and structural resource settings.
In this review article from Future Oncology find out about the potential clinical applications of deregulated miRNAs in cervical cancer.